Detection of fluconazole-resistant Candida strains by a disc diffusion screening test

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 3856-3859

  Sandven, Per ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCREENING;

CANDIDA; CANDIDA ALBICANS;

EID: 0032728571     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.3856-3859.1999     Document Type: Article

References (17)

1. Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.
2. Bille, J. 1997. When should Candida isolates be tested for susceptibility to azole antifungal agents? Eur. J. Clin. Microbiol. Infect. Dis. 16:281-282.
3. Bruun, B., H. Westh, and J. Stenderup. 1995. Fungemia: an increasing problem in a Danish university hospital 1989 to 1994. J. Clin. Microbiol. Infect. 1:124-126.
4. Cantón, E., J. Pemán, A. Carrillo-Muñoz, A. Orero, P. Ubeda, A. Viudes, and M. Gobernado. 1999. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods. J. Clin. Microbiol. 37: 2197-2200.
5. Chakrabarti, A., A. Ghosh, R. Batra, A. Kaushal, P. Roy, and H. Singh. 1996. Antifungal susceptibility pattern of non-albicans Candida species & distribution of species isolated from candidaemia cases over a 5 year period. Indian J. Med. Res. 104:171-176.
6. Cockerill, F. R., J. G. Hughes, E. A. Vetter, R. A. Mueller, A. L. Weaver, D. M. Ilstrup, J. E. Rosenblatt, and W. R. Wilson. 1997. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin. Infect. Dis. 24:403-418.
7. Hung, C. C., Y. C. Chen, S. C. Chang, K. T. Luh, and W. C. Hsieh. 1996. Nosocomial candidemia in a university hospital in Taiwan. J. Formos. Med. Assoc. 95:19-28.
8. Jette, L. P., and C. Sinave. 1999. Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci. J. Clin. Microbiol. 37:1178-1181.
9. Kirkpatrick, W. R., T. M. Turner, A. W. Fothergill, D. I. McCarthy, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Fluconazole disk diffusion susceptibility testing of Candida species. J. Clin. Microbiol. 36:3429-3432.
10. May, J. L., A. King, and C. A. Warren. 1997. Fluconazole disc diffusion testing for the routine laboratory. J. Antimicrob. Chemother. 40:511-516.
11. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
13. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingrof, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
14. Rosco. 1998. Neo-Sensitabs, susceptibility testing. p. 18.0-18.3. A/S Rosco, Taastrup, Denmark.
15. Sandven, P. 1990. Laboratory identification and sensitivity testing of yeast isolates. Acta Odontol. Scand. 48:27-36.
16. Sandven, P., A. Bjorneklett, and A. Maeland. 1993. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrob. Agents Chemother. 37:2443-2448.
17. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.